362 related articles for article (PubMed ID: 10885442)
1. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation.
Schempp CM; Lüdtke R; Winghofer B; Simon JC
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):125-8. PubMed ID: 10885442
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
[TBL] [Abstract][Full Text] [Related]
3. Single-dose and steady-state administration of Hypericum perforatum extract (St John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation.
Schempp CM; Müller K; Winghofer B; Schulte-Mönting J; Simon JC
Arch Dermatol; 2001 Apr; 137(4):512-3. PubMed ID: 11295948
[No Abstract] [Full Text] [Related]
4. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
[TBL] [Abstract][Full Text] [Related]
5. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
6. Skin tolerance of a new bath oil containing St. John's wort extract.
Reuter J; Huyke C; Scheuvens H; Ploch M; Neumann K; Jakob T; Schempp CM
Skin Pharmacol Physiol; 2008; 21(6):306-11. PubMed ID: 18667843
[TBL] [Abstract][Full Text] [Related]
7. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
Boiy A; Roelandts R; van den Oord J; de Witte PA
Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
[TBL] [Abstract][Full Text] [Related]
8. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.
Brockmöller J; Reum T; Bauer S; Kerb R; Hübner WD; Roots I
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():94-101. PubMed ID: 9342768
[TBL] [Abstract][Full Text] [Related]
9. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen.
Bernd A; Simon S; Ramirez Bosca A; Kippenberger S; Diaz Alperi J; Miquel J; Villalba Garcia JF; Pamies Mira D; Kaufmann R
Photochem Photobiol; 1999 Feb; 69(2):218-21. PubMed ID: 10048312
[TBL] [Abstract][Full Text] [Related]
10. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
Beattie PE; Dawe RS; Traynor NJ; Woods JA; Ferguson J; Ibbotson SH
Br J Dermatol; 2005 Dec; 153(6):1187-91. PubMed ID: 16307656
[TBL] [Abstract][Full Text] [Related]
11. Effect of St.John's wort (Hypericum perforatum) oily extract for the care and treatment of pressure sores; a case report.
Yücel A; Kan Y; Yesilada E; Akın O
J Ethnopharmacol; 2017 Jan; 196():236-241. PubMed ID: 28011162
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
13. Severe phototoxic reaction to laser treatment in a patient taking St John's Wort.
Cotterill JA
J Cosmet Laser Ther; 2001 Sep; 3(3):159-60. PubMed ID: 12006194
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Systemic and Topical Hypericum Perforatum on Diabetic Surgical Wounds.
Altıparmak M; Eskitaşçıoğlu T
J Invest Surg; 2018 Feb; 31(1):29-37. PubMed ID: 28107097
[TBL] [Abstract][Full Text] [Related]
15. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
Schempp CM; Winghofer B; Langheinrich M; Schöpf E; Simon JC
Skin Pharmacol Appl Skin Physiol; 1999; 12(5):299-304. PubMed ID: 10461100
[TBL] [Abstract][Full Text] [Related]
16. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy.
Traynor NJ; Beattie PE; Ibbotson SH; Moseley H; Ferguson J; Woods JA
Toxicol Lett; 2005 Sep; 158(3):220-4. PubMed ID: 15890476
[TBL] [Abstract][Full Text] [Related]
17. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
[TBL] [Abstract][Full Text] [Related]
19. St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.
Miller AL
Altern Med Rev; 1998 Feb; 3(1):18-26. PubMed ID: 9600023
[TBL] [Abstract][Full Text] [Related]
20. Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil.
Int J Toxicol; 2001; 20 Suppl 2():31-9. PubMed ID: 11558639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
